📊 BENFW Key Takeaways
Investment Thesis
Beneficient is in severe financial distress with negative stockholders' equity of -$128.6M, indicating liabilities exceed assets by this amount. The company is burning cash at an alarming rate with -$34.8M free cash flow and minimal revenue of $3.3M against massive operating losses of -$106.6M. Without immediate strategic restructuring or significant capital infusion, the company faces existential solvency risk.
BENFW Strengths
- Minimal capital expenditure requirements ($96K) suggests asset-light business model
- Some cash reserves remaining ($7.9M) provides short-term operational runway
- Recent dramatic net income improvement (YoY change suggests loss reduction from prior period)
BENFW Risks
- Negative stockholders' equity of -$128.6M indicates balance sheet insolvency
- Operating cash flow of -$34.7M demonstrates inability to fund operations internally
- Revenue of only $3.3M cannot support $106.6M operating losses; business model is fundamentally broken
- Liabilities exceed assets by $38M with no viable path to profitability visible
- Zero insider buying activity suggests management lacks confidence in recovery
Key Metrics to Watch
- Monthly operating cash flow trend - critical to survival timeline
- Cash balance depletion rate relative to burn rate
- Revenue growth acceleration - need exponential growth to offset losses
- Operating expense reduction progress and restructuring initiatives
- Debt covenant compliance status and refinancing ability
BENFW Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
BENFW Profitability Ratios
BENFW vs Finance Sector
How Beneficient compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
BENFW Balance Sheet & Liquidity
BENFW 5-Year Financial Trend
5-Year Trend Summary: Beneficient's revenue has declined by 106% over the 5-year period, indicating business contraction. The most recent EPS of $-1.27 indicates the company is currently unprofitable.
BENFW Growth Metrics (YoY)
BENFW Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2026 | $3.3M | -$8.6M | N/A |
| Q2 2026 | -$15.4M | N/A | N/A |
| Q1 2026 | -$12.6M | N/A | N/A |
| Q3 2025 | -$55.7M | N/A | N/A |
| Q2 2025 | -$45.5M | N/A | N/A |
| Q1 2025 | -$2.7M | N/A | N/A |
| Q3 2024 | -$86.4M | N/A | N/A |
| Q2 2024 | -$75.0M | N/A | N/A |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
BENFW Capital Allocation
BENFW SEC Filings
Access official SEC EDGAR filings for Beneficient (CIK: 0001775734)
📋 Recent SEC Filings
❓ Frequently Asked Questions about BENFW
What is the AI rating for BENFW?
Beneficient (BENFW) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are BENFW's key strengths?
Minimal capital expenditure requirements ($96K) suggests asset-light business model. Some cash reserves remaining ($7.9M) provides short-term operational runway.
What are the risks of investing in BENFW?
Negative stockholders' equity of -$128.6M indicates balance sheet insolvency. Operating cash flow of -$34.7M demonstrates inability to fund operations internally.
What is BENFW's revenue and growth?
Beneficient reported revenue of $3.3M.
Does BENFW pay dividends?
Beneficient does not currently pay dividends.
Where can I find BENFW SEC filings?
Official SEC filings for Beneficient (CIK: 0001775734) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is BENFW's EPS?
Beneficient has a diluted EPS of $-1.94.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.